What You Should Know:– Reveleer, a value-based care enablement platform launches its next-generation retrospective risk adjustment technology.– The solution leverages artificial intelligence (AI) to improve the accuracy, efficiency, and compliance of risk adjustment programs for payers and providers.Transforming Risk Adjustment with AIIn an increasingly complex healthcare landscape, accurate risk adjustment is essential for ensuring appropriate reimbursement and optimizing care for patients with complex conditions. Reveleer’s new technology addresses the challenges of traditional risk adjustment processes by automating tasks, providing real-time insights, and enhancing collaboration.Reveleer’s AI-powered platform is transforming retrospective risk adjustment by:Improving Accuracy: Reducing coding errors and ensuring more precise RAF capture.Reducing coding errors and ensuring more precise RAF capture. Enhancing Efficiency: Automating tasks and streamlining workflows to improve productivity.Automating tasks and streamlining workflows to improve productivity. Ensuring Compliance: Facilitating adherence to regulatory requirements and reducing audit risk.Facilitating adherence to regulatory requirements and reducing audit risk. Optimizing Performance: Driving better financial outcomes for healthcare organizations.“Our platform is built for those seeking to modernize their risk adjustment programs with artificial intelligence assisted workflows,” said Paul Burke, Chief Product Officer at Reveleer. “By leveraging our proprietary technology and intelligent automation, we provide our customers with the opportunity to increase their efficiency and productivity while improving their RAF accuracy and HCC capture.”

Dave Meyer, Chief AI and Data Officer, ReveleerThe healthcare industry is undergoing a profound transformation, not only in the tools used, but also in how patient care is approached. As the shift toward a value-based care model continues, aligning operations around improving patient outcomes and managing costs effectively is essential. Artificial intelligence (AI) is playing a key role in advancing this transition, helping healthcare organizations deliver better outcomes and reduce costs. However, despite its promise, the adoption of AI in healthcare raises significant ethical concerns. A recent McKinsey survey found that over 70% of respondents from healthcare organizations, including payers, providers, and healthcare services and technology (HST) groups, are either pursuing or have already implemented generative AI capabilities. Yet,  60% of these respondents cite risk concerns, including trust in the technology, as one of their biggest challenges.To fully unlock AI’s benefits, healthcare organizations must address these concerns by prioritizing trust-building through ethical and transparent implementation. This includes ensuring fairness, establishing robust safeguards, and aligning AI solutions with the organization’s broader strategic goals

Reveleer has acquired Curation Health to enhance its value-based care platform with advanced clinical intelligence.